CN203724636U - Obstructive sleep apnea-hypopnea syndrome therapeutic apparatus - Google Patents
Obstructive sleep apnea-hypopnea syndrome therapeutic apparatus Download PDFInfo
- Publication number
- CN203724636U CN203724636U CN201420079529.2U CN201420079529U CN203724636U CN 203724636 U CN203724636 U CN 203724636U CN 201420079529 U CN201420079529 U CN 201420079529U CN 203724636 U CN203724636 U CN 203724636U
- Authority
- CN
- China
- Prior art keywords
- module
- central processing
- processing module
- output
- sleep apnea
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 18
- 208000001797 obstructive sleep apnea Diseases 0.000 title claims abstract description 16
- 201000002859 sleep apnea Diseases 0.000 title abstract 2
- 230000003993 interaction Effects 0.000 claims abstract description 12
- 208000011580 syndromic disease Diseases 0.000 claims description 10
- 230000003321 amplification Effects 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 239000004973 liquid crystal related substance Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 206010003497 Asphyxia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010041235 Snoring Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 210000005181 root of the tongue Anatomy 0.000 description 2
- 238000004088 simulation Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020591 Hypercapnia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 206010057344 Pharyngeal hypertrophy Diseases 0.000 description 1
- 206010058046 Post procedural complication Diseases 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000001584 soft palate Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
Abstract
The utility model provides an obstructive sleep apnea-hypopnea syndrome therapeutic apparatus. The therapeutic apparatus comprises a host, output wires and electrode plates. The host of the therapeutic apparatus is composed of four modules comprising a central processing module, a man-machine interaction module, a power supply module and an output module. The central processing module is connected with the man-machine interaction module and the output module separately, and connected with the electrode plates through the output wires. The central processing module comprises a control CPU. The man-machine interaction module comprises a UICPU, a liquid crystal display screen, a real-time clock, a buzzer and a switch. According to the therapeutic apparatus, advantages of great patient compliance and more applicable patients can be realized, and what a patient needs to do is to attach the electrode plates under the chin during treatment, so advantages of convenient operation and simple utilization can be realized.
Description
technical field:
This utility model relates to a kind of electronic therapeutic instrument, especially a kind of obstructive sleep apnea low syndrome instrument.
background technology:
Obstructive sleep apnea low syndrome (OSAHS) is a kind of sleep-respiratory disease, clinical manifestation have nighttime sleep snoring companion asphyxia and daytime drowsiness.Because asphyxia causes hypoxia at night and the hypercapnia of repeatedly showing effect, can cause hypertension, coronary heart disease, the complication such as diabetes and cerebrovascular disease and vehicle accident, even occur sudden death at night, therefore OSAHS is a kind of sleep-respiratory disease that has potential lethal.
For the treatment of OSAHS, mainly contain clinically following several therapeutic modality:
1. mouthpart treatment
While sleeping with special dilator, put into pharyngeal cavity, pharyngeal cavity is expanded, reduce upper airway resistance.When cause is slept, in mouth, will put dilator, have sense of discomfort, patient is difficult for accepting, and easily causes the oral diseases such as xerostomia halitosis.
2. the radio frequency molten therapy that disappears
Be applicable to light moderate patient, utilize plasma low-temperature to eliminate system, the tissue of pharyngeal hypertrophy is subtracted hold to dwindle, the method is easy, and wound is little, not hemorrhage, generally can be in out-patient treatment, but relapse rate is higher.
3. per nasal positive airway pressure
By air pressurized, patient's air flue is blown open by special respirator, no longer stop up, cure the complication of respiratory tract obstruction anoxia.This method is without wound, but patient need wear nose cup or mask while sleeping, and should, under specialist's guidance, choose and use respirator.Respirator equipment is generally comparatively expensive, wears inconvenience, though because adopting theory of mechanics can significantly improve patient's sleep quality, cannot effect a radical cure symptom.
4. Drug therapy
The medicine of current domestic external enwergy treatment snoring has much, and acetazolamide, thyroxine sheet enhance metabolism, and have certain effect, and period in a medicine can be alleviated, but can not cure, and has side effect.
5. operative treatment
Operative treatment is applicable to unnecessary soft tissue deformity (amygdala hypertrophy, obese patient's soft palate, glossauxeis etc.) and sclerous tissues's deformity (as little micromandibular deformity etc.) and causes the patient that upper respiratory tract is narrow or block.Have wound treatment easily to cause postoperative complication, and Postoperative recurrent rate is higher.
Several therapeutic modalities have drawback and shortcoming separately above.Patient's general adaptedness is not high, even if be decided to be the CPAP respirator of OSAHS treatment goldstandard, and 70% the last abandoning cure of selecting because do not adapt to of patient.
utility model content:
In sum, the purpose of this utility model is drawback in order to overcome existing therapeutic modality and shortcoming and a kind of novel obstructive sleep apnea low syndrome instrument is provided.Temper genioglossus by the electrode slice output electric-impulse stimulation signal stimulus being attached under patient's chin, under chin, skin irritation causes neural excitation and root of the tongue muscle contraction, thereby the plug release symptom of air flue in releasing, long-time use can be repaired the contractility of patient's root of the tongue muscle, the tension force of Airway dilation flesh in raising, reaches and improves even curative effect.
For solving the problems of the technologies described above, the technical solution adopted in the utility model is:
A kind of obstructive sleep apnea low syndrome instrument, this therapeutic instrument comprises main frame, output lead and electrode slice, the main frame of this therapeutic instrument is made up of four modules, comprises central processing module, human-computer interaction module, supply module and output module.
Central processing module is connected with output module with human-computer interaction module respectively, and by output lead connection electrode sheet; Central processing module comprises controls CPU, and human-computer interaction module comprises UICPU, LCDs, real-time clock, buzzer and switch.
Central processing module can produce multiple stimulus waveform, comprises square wave, sine wave and triangular wave.
The stimulus waveform that central processing module produces carries out amplification by the amplifying circuit in output module, and exports with the form of electric current, and the electrode slice connecting by wire connects human body, and obstructive sleep apnea low syndrome is treated.
Compared with prior art, tool has the following advantages this utility model: this therapeutic instrument is wider to large, the applicable patient crowd of patient's compliance, when treatment, only electrode slice need be attached under chin, and easy to operate use is simple.
brief description of the drawings:
Fig. 1 is structural representation of the present utility model;
Fig. 2 is circuit theory diagrams of the present utility model;
Fig. 3 is stimulus waveform figure of the present utility model;
Fig. 4 is amplifying circuit schematic diagram of the present utility model.
detailed description of the invention:
Below in conjunction with drawings and embodiments, this utility model is described in further detail.
As depicted in figs. 1 and 2, a kind of obstructive sleep apnea low syndrome instrument, this therapeutic instrument comprises main frame 1, output lead 2 and electrode slice 3, the main frame 1 of this therapeutic instrument is made up of four modules, comprise central processing module, human-computer interaction module, supply module and output module.
Central processing module is connected with output module with human-computer interaction module respectively, and by output lead 2 connection electrode sheets 3; Central processing module comprises controls CPU, controls the detection that CPU is used for output, output amplitude, output frequency and the voltage and current of controlling stimulation; Human-computer interaction module comprises UICPU, LCDs (LCD), real-time clock (RTC), buzzer (Buzzer) and switch (Switch).
Central processing module can produce multiple stimulus waveform, comprises square wave, sine wave and triangular wave.
Taking square wave as example, as shown in Figure 3, in whole therapeutic process, first stimulate N pulse under patient's chin below, stop after T second, more then stimulate N pulse, until press stop button or treatment time arrives; Wherein square wave frequency, dutycycle and amplitude are adjustable; N is integer, and N>1; Dwell time T is also integer, and T >=0.The output of square wave is that the DA being carried by control CPU is that digital to analog converter partial simulation is exported, and the frequency of this pulse and dutycycle can be controlled by the intervalometer of controlling in CPU, and amplitude is controlled by the depositor of controlling in CPU.The simulation square wave of controlling CPU output stimulates under patient's chin by conducting wire connection electrode sheet by after amplifying.
As shown in Figure 4, will export square wave amplitude by operational amplifier U1 and amplify, carry out power amplification by Q1 and two audions of Q2, finally the stimulus waveform after amplifying be exported by output module.
What this utility model patent adopted is the therapeutic modality of square wave, this therapeutic instrument also can other waveform as other waveforms such as sine wave, triangular wave, modulating waves.DA output is wherein the DA part output by central processing module inside, also can pass through DA chip, other waveform generation chip or circuit and substitute.
Claims (3)
1. an obstructive sleep apnea low syndrome instrument, this therapeutic instrument comprises main frame, output lead and electrode slice, it is characterized in that: the main frame of this therapeutic instrument is made up of four modules, comprises central processing module, human-computer interaction module, supply module and output module; Central processing module is connected with output module with human-computer interaction module respectively, and by output lead connection electrode sheet; Central processing module comprises controls CPU, and human-computer interaction module comprises UICPU, LCDs, real-time clock, buzzer and switch.
2. a kind of obstructive sleep apnea low syndrome instrument according to claim 1, is characterized in that: central processing module can produce stimulus waveform and comprise square wave, sine wave and triangular wave.
3. a kind of obstructive sleep apnea low syndrome instrument according to claim 1 and 2, is characterized in that: stimulus waveform is exported by amplifying circuit amplification.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420079529.2U CN203724636U (en) | 2014-02-25 | 2014-02-25 | Obstructive sleep apnea-hypopnea syndrome therapeutic apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420079529.2U CN203724636U (en) | 2014-02-25 | 2014-02-25 | Obstructive sleep apnea-hypopnea syndrome therapeutic apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203724636U true CN203724636U (en) | 2014-07-23 |
Family
ID=51194740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420079529.2U Expired - Fee Related CN203724636U (en) | 2014-02-25 | 2014-02-25 | Obstructive sleep apnea-hypopnea syndrome therapeutic apparatus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203724636U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103800999A (en) * | 2014-02-25 | 2014-05-21 | 郑州雅晨生物科技有限公司 | Obstructive sleep apnea hypopnea syndrome therapeutic apparatus |
-
2014
- 2014-02-25 CN CN201420079529.2U patent/CN203724636U/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103800999A (en) * | 2014-02-25 | 2014-05-21 | 郑州雅晨生物科技有限公司 | Obstructive sleep apnea hypopnea syndrome therapeutic apparatus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210321939A1 (en) | Detecting and treating disordered breathing | |
| EP3533489A1 (en) | Apparatus for treating sleep apnea | |
| CN203816090U (en) | Labor analgesia instrument | |
| CN110353874B (en) | Sleep disordered breathing treatment system | |
| CN202505987U (en) | Sleep apnea therapeutic device based on external diaphragm pacing | |
| CN113423366A (en) | Method and apparatus for treating sleep apnea | |
| CN102429643B (en) | Snore gauge | |
| CN102058396A (en) | Handheld cortex egersimeter and cortex electrostimulation | |
| CN203724636U (en) | Obstructive sleep apnea-hypopnea syndrome therapeutic apparatus | |
| CN202538166U (en) | Digital insomnia therapeutic instrument | |
| CN108742996A (en) | A kind of electro photoluminescence snore stopper and operation principle and working method based on smart mobile phone control | |
| CN201020155Y (en) | Electronic scrape therapeutic equipment | |
| CN203208539U (en) | Ejaculation adjustment and control instrument | |
| CN103800999A (en) | Obstructive sleep apnea hypopnea syndrome therapeutic apparatus | |
| CN204951946U (en) | Swallow neural muscle electricity stimulation instrument | |
| CN204379521U (en) | A kind of stuffy nose relieving device for health care | |
| CN201379899Y (en) | EEG alpha wave interference-inducing music therapeutic instrument | |
| CN204734599U (en) | Alleviate and treat wrist -watch of snoring | |
| CN107157639A (en) | A kind of transcutaneous electrostimulation device for preventing snoring | |
| CN205108780U (en) | Laser snore relieving appearance | |
| CN203724634U (en) | Desktop obstructive sleep apnea-hypopnea syndrome therapeutic apparatus | |
| WO2018000650A1 (en) | Acupoint electrical stimulation method and device for adjuvant treatment of inflammatory pain | |
| CN203724635U (en) | Portable obstructive sleep apnea-hypopnea syndrome therapeutic apparatus | |
| CN202198971U (en) | Device for recovering nerve functions | |
| CN215231611U (en) | Device for treating obstructive sleep apnea syndrome by using composite wave |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140723 |